News
Comphya strengthens its team with the appointment of Pierre Chauvineau as new Board of Director
10 February 2021PRESS RELEASE Lausanne, Switzerland, February 10th, 2021. Comphya SA, the developer of CaverSTIMÒ, the first implantable neurostimulator to restore erectile function in non-responders to oral...
Read more
Comphya raises additional USD 1.3 million to secure the execution of the pilot clinical trials to start early 2021
01 December 2020PRESS RELEASE Lausanne, Switzerland, December 01st, 2020. Comphya SA, a developer of the first neuromodulator to treat erectile dysfunction, today announced the fundraising of USD...
Read more
CaverSTIM system is now powered by ACCEL+ IPG platform.
21 October 2020PRESS RELEASE Lausanne, Switzerland, October 21th, 2020. Comphya SA, the developer of CaverSTIM, and Cirtec Medical Corp. today announced their decision to transfer the development...
Read more
Comphya appoints Mikael Sturny as Chief Technology Officer.
02 October 2020PRESS RELEASE Lausanne, Switzerland, September 22, 2020 - Comphya SA, the developer of CaverSTIM, announced today the appointment of Mikael Sturny as Chief Technology Officer....
Read more
Comphya is delighted to announce the formation of the Clinical Advisory Board
10 February 2020PRESS RELEASE Lausanne, Switzerland, February 07th, 2020 - Comphya SA, the developer of CaverSTIM™, the first implantable neurostimulator to restore erectile function in non-responders to...
Read more
Comphya SA and Cirtec Medical Corp. announce the partnership on the development of CaverSTIM
25 October 2019PRESS RELEASE Comphya SA announces partnership with Cirtec Medical Corp. on the development of the first implantable neurostimulator to treat Erectile Dysfunction. Lausanne, Switzerland, October...
Read more
Comphya raises USD 3.0 million in the first financing round and appoints Dr Steve Swinson as Chairman of the Board
25 July 2019Comphya SA, a developer of a novel implantable neurostimulator to treat erectile dysfunction in non-responders to oral drugs, today announced the fundraising of USD 3.0...
Read more
First publication – Proof of concept
15 November 2018Journal of Sexual Medicine published our results on the acute clinical trial (20 patients) which demonstrated the proof of the principle and technology feasibility....
Read more